Elementerre BIO

The computed 12-month bankruptcy probability of Elementerre BIO is 3.6% (moderate). The annual accounts of Elementerre BIO for financial year 2025 show a net loss of 65% of the equity at the start of that year. The 2025 annual accounts show equity of €9,741 and a net result of -€17,865. Equity is shrinking by about 49% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2026. Its solvency ranks better than 28% of 22,679 sector peers (NACE 47, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.